Mobility problems and lameness in a flock can have many causes as well as contributing factors
including management, nutrition, bacterial infections, and viral infections. Do you have leg issues in
your barn? Are you observing an increased amount of “hockey sticks” or “green hock” legs? How
much of your flock is affected? Is this a recurrent issue?
Although there are several non-infectious potential causes for lameness including: management (e.g.
incubation & handling issues), and nutrition (e.g. Vit B deficiency, Rickets); one of the most important
in recent years is a viral disease known as “Viral Tenosynovitis, or “Viral Arthritis” (VA). In this short
article, we aim to explain what VA is, as well asto describe some contributing factors and some control
strategies to be implemented in the field. This is important, as this “old” disease has reemerged as a
risk to bird health due to the emergence of variant Avian ReoViruses (ARVs) resistant to the immunity
conferred by commercial vaccines.

What is Viral Arthritis (VA)?
First reported in 1957, this disease is one of the many clinical manifestations of Avian Reovirus (ARV)
infections in poultry. Other clinical manifestations are “runting-stunting” syndrome—characterized by
an impairment of the growth of the animal and mainly affecting the gut —as well as hepatitis,
myocarditis, and hydropericardium.
Viral Arthritis is characterized by visible swelling of the hock joints, and tarsal and metatarsal tendons,
which cause reluctance to move and can be present together with bacterial infection (e.g.
Staphylococcus aureus, Escherichia coli and Mycoplasma synoviae infections). As a result, the
swelling is increased and the lesions become more serious; also, fibrosis of the tendons caused by a
chronic infection may develop into a rupture of the gastrocnemius tendon and hemorrhage with leads
to “green hock” legs, as observed in the field (Fig 1). Thus, the disease not only has economic
implications (i.e. low uniformity, processing plant condemnations), but it is also a welfare problem (i.e.
increased culling, decreased access to feed & water), and may also result in the additional use of
antibiotics to deal with secondary infections.

When and why does VA occur?
The disease is transmitted horizontally (from bird to bird), as well as vertically (from hens to progeny).
It requires that susceptible birds are infected at a very young age for clinical signs to develop later in
life. This is one of the most important parts in the biology of the disease: as a parent stock bird is
infected by ARV, a minimal number of progeny embryos/chicks will be ARV-positive, which may
later shed the virus to a susceptible population of young birds in a given placement from, perhaps, many
different parent stock sources.
This disease has been effectively controlled for many years through the live and inactivated vaccines
developed in the 1980s. However, since 2011, VA emerged in Canadian broiler flocks and in several
areas in the US in a relatively short period of time. Also, numerous turkey flocks in North Central
United States have been experiencing turkey viral arthritis since 2009. Since then, several genotypes
which are different from classic commercial vaccines have been described in production animals.
Several researchers have also come up with their own way to classify these variants, which may
generate confusion when trying to compare results between labs. At PHS, we currently use the Kant
classification system, which is the same used by the University of Georgia (UGA). It consists of the
molecular sequencing of the sigma-C protein, which is the most important ARV protein responsible for
inducing neutralizing antibodies, conferring protection against challenge. All ARV reported genotypes
have been found circulating in Canada since 2011, including the newest “Genotype 7” in Ontario Although
many of these genotypes were found and classified in Europe by Kant et al (2003), it is unclear as to how
these ARVs found their way to North America and how they spread so fast acrossthe whole continent.

As classical commercial vaccines do not immunize against these new variant viruses, the industry
started to immunize parent stocks with autogenous vaccines, an “emergency-only” kind of vaccine
subject to fewer and simpler regulations that allows the inclusion of non-classical virus from the field
in an inactivated oil-based vaccine. Even with an autogenous vaccine, it can take between 6 months to
1 year from the moment an ARV is isolated until a batch of vaccine is ready for application in broiler
breeders. Our experience with autogenous ARV control started with 35 cases and 19 viruses isolated
in 2012 allowing vaccine development and implementation in 2013.
Interestingly, ARV control has been regarded as a “moving target”. It has been documented that once
an autogenous vaccine against certain genotypes has been extensively used then other ARV genotypes,
not affected by the immunity induced by the autogenous vaccines, replace them as new field challenge

What do I do if I think I have VA in my flock?
Start with a diagnosis from your vet and an accredited lab. Proper collection and submission of the
right samples at the right time will greatly increase the success in a definitive diagnosis. A definitive
diagnosis of ARV arthritis requires clinical signs, confirmation of gross and microscopic lesions (heart
and tendon), molecular testing, and most importantly virus isolation and/or typing. There are many
non-pathogenic REO viruses naturally occurring in the gut of normal chickens so finding REO virus in
a bird or bird sample is normal and does not necessarily have any connection with the problems you
may be seeing. We have been testing the pathogenicity of our field isolates and the ability of
autogenous vaccines to protect in breeder vaccination and live bird clinical challenge models in
cooperation with an Institute for Applied Poultry Technologies funded project at the University of
Alberta and the University of Calgary. Field and clinical trials indicate that live REO vaccines do not
protect against many of the variant strains and using them in an infected flock may result in an
increased challenge and the potential risk for genetic reassortment.
There is no treatment for this disease so a proper work up is required to build the autogenous vaccines
the industry is using to protect the flocks. Since affected birds will not recover from the disease, the
economic impact can be reduced through good management practices (e.g. proper distribution of feed
and water, suitable environment), and culling of the affected birds. Growth rates are naturally reduced
during an active infection, but your vet may also recommend altering your lighting program to manage
later growth rates and stress on the birds and their damaged tendons.
We recommend submitting your case as soon as possible to rule out potential causes and also to be
included in an ARV monitoring program. Monitoring and autogenous vaccination development at the
industry level is the recommended management plan for this disease.
Avian reovirus is amongst the most resistant viruses on earth. However, removal/treatment of built-up
litter, effective use of disinfectants according to their label directions, heat treatment of affected houses
during downtime, and increased downtime will decrease the ARV viral load on the next production
cycle. In short, a diligent cleaning and disinfection process is crucial to diminish the economic impact
of the disease.